FerInject: Clinical Trials

5 trials of FerInject, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 1, Unknown 1
Phase 31Terminated 1

Follow FerInject: new trials by email Literature Review of FerInject trials Research Report on FerInject

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
Ferric Carboxymaltose, blood withdrawal - Heart Failure, Systolic, Iron Deficiency
Phase 2CompletedRWTH Aachen University232017-03-102017-12-06
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
FerInject, Ferro sanol - Metastatic Colorectal Cancer
Phase 2CompletedInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest642015-03-012020-10-19
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
Ferric carboxymaltose, Placebo - Chronic Fatigue, Inflammatory Bowel Disease
Phase 2UnknownIstituto Clinico Humanitas362014-10-012015-09-10
Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy
Ferinject (Ferric Carboxymaltose) - Pancreatic Cancer, Anemia
Phase 2CompletedNational Cancer Center, Korea402014-01-012020-04-28
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
Ferric carboxymaltose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Puerperal Disorders
Phase 2 / Phase 3TerminatedNorwegian University of Science and Technology302009-06-012012-02-17

Conditions studied

Anemia, Iron-Deficiency (2)  ·  Anemia (1)  ·  Colitis, Ulcerative (1)  ·  Colorectal Neoplasms (1)  ·  Crohn Disease (1)  ·  Depression, Postpartum (1)  ·  Fatigue (1)  ·  Heart Failure, Systolic (1)  ·  Inflammatory Bowel Diseases (1)  ·  Iron Deficiencies (1)  ·  Pancreatic Neoplasms (1)  ·  Puerperal Disorders (1)

Sponsors

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)  ·  Istituto Clinico Humanitas (1)  ·  National Cancer Center, Korea (1)  ·  Norwegian University of Science and Technology (1)  ·  RWTH Aachen University (1)

Countries

Germany (2)  ·  Italy (1)  ·  Norway (1)  ·  South Korea (1)

Top investigators

Bjorn Backe, MD PhD (1)  ·  Sang Jae Park, M.D (1)

Results publications

PMID 10029607, PMID 10924610, PMID 11910485, PMID 17330243, PMID 1990875, PMID 2354408, PMID 29747838, PMID 3492188, PMID 6125797, PMID 6234037

NIH funding

2008 (1)